Cargando…
Methylation of N6 adenosine‐related long noncoding RNA: effects on prognosis and treatment in ‘driver‐gene‐negative’ lung adenocarcinoma
The improvement of treatment for patients with ‘driver‐gene‐negative’ lung adenocarcinoma (LUAD) remains a critical problem to be solved. We aimed to explore the role of methylation of N6 adenosine (m6A)‐related long noncoding RNA (lncRNA) in stratifying ‘driver‐gene‐negative’ LUAD risk. Patients ne...
Autores principales: | Yang, Hao‐Shuai, Cai, He‐Yuan, Shan, Shi‐Chao, Chen, Ting‐Fei, Zou, Jian‐Yong, Abudurufu, Maimaiti, Luo, Hong‐He, Lei, Yi‐Yan, Ke, Zun‐Fu, Zhu, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892826/ https://www.ncbi.nlm.nih.gov/pubmed/36221911 http://dx.doi.org/10.1002/1878-0261.13323 |
Ejemplares similares
-
A radiomics nomogram prediction for survival of patients with “driver gene-negative” lung adenocarcinomas (LUAD)
por: Guo, Qi-Kun, et al.
Publicado: (2023) -
lncRNA VIM-AS1 acts as a prognostic biomarker and promotes apoptosis in lung adenocarcinoma
por: Kang, Jianhong, et al.
Publicado: (2023) -
A novel signature based on immune‐related gene pairs and clinical features to predict prognosis and treatment effect in “driver gene negative” lung adenocarcinoma
por: Cai, He‐yuan, et al.
Publicado: (2022) -
Dishevelled Segment Polarity Protein 3: A Novel Prognosis-related Marker in Pan-driver-gene-negative Lung Adenocarcinoma
por: Cui, Yongmei, et al.
Publicado: (2023) -
Construction of a lung adenocarcinoma prognostic model based on N6-methyl-adenosine-related long noncoding RNA and screening of potential drugs based on this model
por: Hou, Qinghua, et al.
Publicado: (2022)